Our Firm regularly hears from women who received implants from Ethicon, C.R. Bard and other companies.
New York, NY (PRWEB) September 14, 2014
Transvaginal mesh (http://www.injurybeacon.com/transvaginal-mesh/) lawsuits are continuing to be filed in New Jersey, where two separate litigations are moving forward in Atlantic County Superior Court, Bernstein Liebhard LLP reports.
According to Case Lists updated on September 5th, thousands of lawsuits have now been filed over devices marketed by C.R. Bard Inc., and Johnson & Johnson’s Ethicon unit. In a consolidated proceeding involving cases against C.R. Bard, a total of 1,557 claims have now been filed, while the litigation involving Ethicon’s Gynecare product line now includes more than 7,000 lawsuits. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10) (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
“We are not surprised that the number of lawsuits continues to increase in the two mesh litigations underway in Atlantic County, as our Firm regularly hears from women who received implants from Ethicon, C.R. Bard and other companies,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to women who may have suffered pain, erosion, scarring, infection and other side effects allegedly caused by transvaginal mesh.
Transvaginal Mesh Lawsuits
Transvaginal mesh lawsuits have continued to increase since 2008, when the U.S. Food and Drug Administration (FDA) first warned about their potential to cause serious injuries. At the time, the FDA said it received at least 1,000 reports of serious injuries associated with pelvic mesh implants over three years. In July 2011, the federal agency issued a second Public Health Alert indicating that the number of transvaginal mesh injury reports had tripled since 2008. The FDA said at the time that such injuries were “not rare,” which was a modification of its previous stance that they were “rare.”
The nationwide law firm of Bernstein Liebhard LLP is actively involved in New Jersey’s consolidated mesh litigations. Firm partner, Jeffrey S. Grand, is currently serving as Co-Liaison Counsel in both the C.R. Bard and Ethicon proceedings. For the Ethicon litigation, Mr. Grandwas also a member of the Plaintiff’s trial team in a case that concluded in March 2013 with an $11 million damage award to a woman who was injured by the company’s Prolift device. (Gross v. Gynecare Inc., Atl-L-6966-10)
At the federal court level, transvaginal mesh lawsuits are moving forward as well. Court documents show 19,380 Ethicon lawsuits now filed in a multidistrict litigation established in the U.S. District Court, Southern District of West Virginia, where nearly 9,600 claims over C.R. Bard have now been centralized in a separate proceeding established there. Mr. Grand is serving on the Plaintiffs’ Steering Committee in both these litigations, as well as those involving American Medical Systems, Inc. and Boston Scientific Corp. (Ethicon, Inc. (MDL No. 2327), American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).
On September 5th, the jury hearing the second bellwether trial in the federal Ethicon litigation returned a $3.27 million verdict in favor of a woman who suffered complications related to erosion of her Gynacare TVT O-Mesh device. (Huskey v. Ethicon, Case No. 12-5201)
Just days later, a jury in Texas state court ordered on September 8th that Boston Scientific pay $73 million in compensatory and punitive damage to a woman who was harmed by the company’s Obtryx sling. (Salazar v. Lopez, No. DC-1214349, District Court for Dallas County, 95th Judicial District of Texas (Dallas))
According to court documents, all transvaginal mesh lawsuits filed in these litigations allege chronic pain, scarring, painful sexual intercourse and other injuries caused by the implants. Plaintiffs further accuse manufacturers of failing to adequately warn doctors and patients about risks that may be associated with their products.
Women who were allegedly injured as a result of transvaginal mesh may be able to pursue their own legal claim against the manufacturer of their device. Learn more about the ongoing transvaginal mesh litigation, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by
The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP